- home
- facet
- Imvanex
Imvanex
perspectives
countries
- 1.United States
- 2.China
- 3.Denmark
- 4.France
- 5.United Kingdom
- 6.Japan
- 7.Kenya
- 8.Mozambique
- 9.Nigeria
- 10.Philippines
- 11.Pakistan
- 12.Russian Federation
organizations
- 1.World Health Organization
- 2.Africa Centers for Disease Control and Prevention
- 3.Bavarian Nordic
- 4.European Union
- 5.KM Biologics
- 6.Pasteur Institute
- 7.United Nations
- 8.US Centers for Disease Control and Prevention
- 9.Emergent BioSolutions
- 10.European Center for Disease Prevention and Control
- 11.European Commission
- 12.European Health Emergency Preparedness and Response Authority
persons
- 1.Dimie Ogoina
- 2.Jean Kaseya
- 3.Federico Jofré
- 4.Hans Kluge
- 5.Kocha Olarn
- 6.Magnus Gisslen
- 7.Mauricio Torres
- 8.Maya Davis
- 9.Paul Chaplin
- 10.Stuart Blume
- 11.Tedros Adhanom Ghebreyesus
- 12.Ayona Munyakazia
technicals
- 1.Clade I mpox
- 2.Covid-19 Pandemic
- 3.Jynneos
- 4.LC16
- 5.mpox
- 6.ACAM2000
- 7.Hera
- 8.Imvamune
- 9.OrthopoxVac
- 10.MVA-BN